Description
Composition- Vildagliptin SR 100 mg + Dapagliflozin 10 mg + Metformin SR 500 mg
Mode of Action- Combines incretin-based glucose control, SGLT2 inhibition and metformin-mediated insulin sensitization for comprehensive diabetes management.
USPs- Triple diabetes pathway support; balanced metformin strength; useful in uncontrolled type 2 diabetes.
Prescribing Specialties- Diabetologist, General Physician
